Stay updated on Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.

Latest updates to the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 removed, indicating a minor metadata update to the page.SummaryDifference0.1%

- Check18 days agoChange DetectedAdded a new 'Moffitt Cancer Center Clinical Trials website' link and the sponsor organization name 'H. Lee Moffitt Cancer Center and Research Institute.' Introduced a new 'Helpful Links Provided by' section to house related links.SummaryDifference0.2%

- Check25 days agoChange DetectedDeleted the Study Protocol and Statistical Analysis Plan PDF along with several boilerplate/footer items from the study page.SummaryDifference20%

- Check32 days agoChange DetectedThe update appears to be a site-wide template revision (Revision: v3.4.2) with removal of certain footer sponsor links; these changes do not modify the trial details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check39 days agoChange DetectedThe page revision updates from v3.4.0 to v3.4.1, with no substantive changes to study details, eligibility criteria, outcomes, or timelines.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now shows Last Update Posted instead of Last Update Posted (Estimated), clarifying the update timestamp. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.